We identified several targets of IGF2BP3 linked to cell motility and invasion processes, including HMGA1, ZMIZ1, and LPCAT3. These targets have been implicated in tumor recurrence, metastasis promotion, regulation of cell migration, and patient survival (Mathios et al, 2019; Ouyang et al, 2022; Rogers et al, 2013; Wang et al, 2019; Zhu et al, 2022). Here, IGF2BP3 is linked to neoplasm.